# CYP2B6 Polymorphisms in Ketamine

> **NCT01988922** · NA · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 30 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ketamine

## Key facts

- **NCT ID:** NCT01988922
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-11
- **Primary completion:** 2016-05
- **Final completion:** 2017-05
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01988922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01988922, "CYP2B6 Polymorphisms in Ketamine". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01988922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*